ID
12725
Description
High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00136448
Link
https://clinicaltrials.gov/show/NCT00136448
Keywords
Versions (1)
- 12/11/15 12/11/15 - Julian Varghese
Uploaded on
December 11, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myelogenous Leukemia NCT00136448
Eligibility Acute Myelogenous Leukemia NCT00136448
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
History of an antecedent hematologic malignancy such as myelodysplastic syndromes (mds).
Data type
boolean
Alias
- UMLS CUI [1]
- C0376545
Description
Uncontrolled infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0517627
Description
History of a previous or concomitant malignancy other than non-melanoma skin cancer.
Data type
boolean
Alias
- UMLS CUI [1]
- C2735088
- UMLS CUI [2,1]
- C0009488
- UMLS CUI [2,2]
- C0006826
Description
Evidence of central nervous system (cns) leukemia.
Data type
boolean
Alias
- UMLS CUI [1]
- C1332884
Description
Current use of corticosteroids.
Data type
boolean
Alias
- UMLS CUI [1]
- C0001617
Description
Prior treatment for aml, other than hydroxyurea.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0023467
Similar models
Eligibility Acute Myelogenous Leukemia NCT00136448
- StudyEvent: Eligibility
C0201899 (UMLS CUI [2])
C0201850 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
C0009488 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C0023467 (UMLS CUI [1,2])